Data from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Jean‐Luc Coll et al.|Unknown|2023Cited by 0
Supplementary Tables 1-6 from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0
Supplementary Figures 1-10 from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0
Supplementary Methods and Materials from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0
Supplementary Methods and Materials from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0